This is a news story, published by Telegraph, that relates primarily to Philip Morris International news.
For more health policy news, you can click here:
more health policy newsFor more news from Telegraph, you can click here:
more news from TelegraphOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about health policy, you might also like this article about
Marlboro cigarette maker Philip Morris. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Vectura Group news, inhaler brand news, news about health policy, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
inhaler manufacturerTelegraph
•
58% Informative
Philip Morris International bought Vectura Group three years ago as part of a plan to transform itself into a broader healthcare and wellness’ group.
The company had faced medical boycotts, including being barred from a major medical conference shortly after the takeover.
PMI had already taken a $ 680 m (516bn) impairment against the unit and abandoned its growth plans.
VR Score
49
Informative language
42
Neutral language
59
Article tone
formal
Language
English
Language complexity
62
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links